Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: Decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione

Endocrinology

Volumn 140, Issue 3, 1999, Pages 1151-1157

  Cooksey, Robert C ^a,c   Hebert Jr , Leon F ^a   Zhu, Ju Hong ^b   Wofford, Perisco ^a   Garvey, W Timothy ^b,d   McClain, Donald A ^a,c,e  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE TRANSPORTER; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; TROGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HORMONE ACTION; HYPERGLYCEMIA; INSULIN RESISTANCE; MOUSE; MUSCLE FIBER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SKELETAL MUSCLE; TRANSGENIC MOUSE;

EID: 0032915738     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.3.6563     Document Type: Article

References (37)

1. 1. Koranyi L, Bourey R, Vuorinen-Makkola H, Koivisto VA, Mueckler M, Permutt MA 1991 Level of skeletal muscle glucose transporter protein correlates with insulin stimulated whole body glucose disposal in man. Diabetologia 34:763-765
2. 2. Olefsky JM 1993 Insulin resistance and the pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms. Adv Exp Med Biol 334:129-150
3. 3. Rossetti L, Giaccari A, DeFronzo RA 1990 Glucose toxicity. Diabetes Care 3:610-630
4. 4. Yki-Järvinen H 1992 Glucose toxicity. Endocr Rev 13:415-431
5. 5. Marshall S, Bacote V, Traxinger RR 1991 Discovery of a metabolic pathway mediating glucose induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712
6. 6. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N 1995 In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96:132-140
7. 7. Baron A, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT 1995 Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 96:2792-2801
8. 8 Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG 1995 Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44:1438-1446
9. 9 Hebert Jr LF, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu JS, Baron AD, McClain DA 1996 Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936
10. 10. Ariano MA, Armstong RB, Edgerton VR 1972 Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 21:51-55
11. 11. Brozinick Jr JT, Qaspelkis III BB, Wilson CM, Grant KE, Gibbs EM, Cushman SW, Ivy JL 1996 Glucose transport and GLUT4 protein distribution in skeletal muscle of GLUT4 transgenic mice. Biochem J 313:133-140
12. 12. Klip A, Ramlal T, Young DA, Holloszy JO 1987 Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224:224-230
13. 13. Klip A, Ramlal T, Bilan PJ, Cartee GD, Gulve EA, Holloszy JO 1990 Recruitment of GLUT4 glucose transporter by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun 172:728-736
14. 14. Avruch J, Wallach DFH 1971 Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim Biophys Acta 233:334-347
15. 15. Forbush B 1983 Assay of Na/K-ATPase in plasma membranes. Anal Biochem 128:159-163
16. 16. Palmer CJ, Scott BT, Jones LR 1991 Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 266:11126-11130
17. 17. Walaas SI, Horn RS, Albert KA, Adler A, Walaas O 1988 Phosphorylation of multiple sites in a 15000 dalton proteolipid from rat skeletal muscle sarcolemma, catalyzed by adenosine 3′,5′-monophosphate dependent and calcium/ phospholipid-dependent protein kinases. Biochim Biophys Acta 968:127-137
18. 18. Laemmli UK 1970 Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685
19. 19. Towbin H, Staehelin T, Gordon J 1979 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
20. 20. Garvey WT, Maianu L, Hancock J, Golichowski AM, Baron AD 1992 Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41:465-475
21. 21. James DE, Strube M, Mueckler M 1989 Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338:83-87
22. 22. McClain DA, Crook ED 1996 Hexosamines and insulin resistance. Diabetes 45:1003-1008
23. 23. Garvey WT, Olefsky JM, Matthaei S, Marshall S 1987 Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. J Biol Chem 262:189-197
24. 24. Barzilai N, Hawkins M, Angelox I, Hu M, Rossetti L 1996 Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 45:1329-1335
25. 25. Balkan B, Dunning BE 1994 Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 43:1173-1179
26. 26. Hresko RC, Heimberg H, Chi MM-Y, Mueckler M 1998 Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273:20658-20668
27. 27. Camirand A, Marie V, Rabelo R, Suva JE 1998 Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissue and skeletal muscle. Endocrinology 139:428-431
28. 28. Elbrecht A, Chen Y. Cullinan CA, Hayes N, Leibowitz MD, Moller DE, Berger J 1996 Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224:431-437
29. 29. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J 1997 Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ. J Biol Chem 272:28210-28217
30. 30. Mukherjee R, Jow L, Croston GE, Paterniti JR 1997 Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid x receptor agonists and antagonists. J Biol Chem 272:8071-8076
31. 31. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS 1997 Peroxisomne proliferator-activated receptor gene expression in human tissues. J Clin Invest 99:2416-2422
32. 32. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR 1997 PPARγ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46:1230-1234
33. 33. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D 1998 Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273:8560-8563
34. 34. Miles PDG, Kigo K, Romeo OM, Lee MK, Rafaat K, Olefsky JM 1998 Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance. Diabetes 47:395-400
35. 35. Hart GW, Greis KD, Dong LYD, Blomberg MA, Chou TY, Jiang MS, Roquemore EP, Snow DM, Kreppel LK, Cole RN, Comer FI, Arnold CS, Hayes BK 1995 O-linked N-acetylglucosamine: the "yin-yang" of Ser/Thr phosphorylation? In: Alavi A, Axford JS (eds) Glycoimmunology. Plenum Press, New York, pp 115-123
36. 36. Chou TY, Hart GW, Dang CV 1995 c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270:18961-18965
37. 37. Daniels MC, Kansal P, Smith TM, Paterson AJ, Kudlow JE, McClain DA 1993 Glucose regulation of transforming growth factor-α expression is mediated by products of the hexosamine biosynthesis pathway. Mol Endocrinol 7:1041-1048